MESO Competitors & Alternatives
Compare Mesoblast Ltd with similar stocks in the same industry
Biotechnology
MESO
Main Stock$14.32
Tradestie Score
63
Market Cap
$2.08B
Revenue Growth
3.9%
Analyst Upside
+158.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.57
|
$2.02B | - | 45 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.12
|
$2.01B | - | 51 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.59
|
$1.97B | - | 62 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$7.29
|
$1.92B | - | 46 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$75.13
|
$1.92B | - | 43 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$27.99
|
$1.90B | 9.2 | 41 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.99
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.54
|
$1.81B | - | 74 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.91
|
$1.78B | - | 34 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.82
|
$1.78B | - | 50 | Compare |
More MESO Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry